Canandaigua National Bank & Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Canandaigua National Bank & Trust CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	SELL	$680.49 - $826.97 $2.21 Million - $2.68 Million	-3,242 Closed	0 $0
Q1 2020 Apr 16, 2020	SELL	$336.18 - $494.43 $122,369 - $179,972	-364 Reduced 10.09%	3,242 $1.58 Million
Q4 2019 Jan 17, 2020	SELL	$274.13 - $376.51 $34,814 - $47,816	-127 Reduced 3.4%	3,606 $1.35 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $36,917 - $42,982	-135 Reduced 3.49%	3,733 $1.04 Million
Q2 2019 Jul 19, 2019	SELL	$299.6 - $414.82 $2,996 - $4,148	-10 Reduced 0.26%	3,868 $1.21 Million
Q1 2019 Apr 25, 2019	SELL	$372.08 - $439.57 $21,952 - $25,934	-59 Reduced 1.5%	3,878 $1.59 Million
Q4 2018 Feb 06, 2019	SELL	$335.82 - $403.04 $105,111 - $126,151	-313 Reduced 7.36%	3,937 $1.47 Million
Q3 2018 Nov 02, 2018	SELL	$351.14 - $408.51 $25,633 - $29,821	-73 Reduced 1.69%	4,250 $1.72 Million
Q2 2018 Aug 03, 2018	SELL	$284.6 - $344.99 $38,990 - $47,263	-137 Reduced 3.07%	4,323 $1.49 Million
Q1 2018 May 09, 2018	BUY	$315.82 - $393.78 $1.41 Million - $1.76 Million	4,460 New	4,460 $1.54 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.